Cargando…

Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception

Objective: The number of students using prescription drugs to improve cognitive performance has increased within the last years. There is first evidence that the expectation to receive a performance-enhancing drug alone can result in improved perceived and actual cognitive performance, suggesting a...

Descripción completa

Detalles Bibliográficos
Autores principales: Winkler, Alexander, Hermann, Christiane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640161/
https://www.ncbi.nlm.nih.gov/pubmed/31354552
http://dx.doi.org/10.3389/fpsyt.2019.00498
_version_ 1783436591857926144
author Winkler, Alexander
Hermann, Christiane
author_facet Winkler, Alexander
Hermann, Christiane
author_sort Winkler, Alexander
collection PubMed
description Objective: The number of students using prescription drugs to improve cognitive performance has increased within the last years. There is first evidence that the expectation to receive a performance-enhancing drug alone can result in improved perceived and actual cognitive performance, suggesting a substantial placebo effect. In addition, expecting a placebo can result in lower perceived and actual cognitive performance, suggesting a nocebo effect. Yet, the underlying mechanisms of these effects remain to be elucidated. The aim of our study was to investigate whether the expectation of receiving a performance-increasing drug or a performance-impairing drug leads to changes in actual and perceived cognitive performance, compared to a control group without expectation manipulation. Methods: A total of N = 75 healthy adults were recruited for an experiment to “try cognitive performance-modulating drugs.” A participant’s actual cognitive performance (alertness, working memory, sustained attention, and divided attention) using the standardized test of attentional performance (TAP) as well as their performance expectation were assessed. Participants were randomly assigned in equal numbers to either receiving a placebo performance increasing nasal spray (“Modafinil”) or a nocebo performance impairing nasal spray (“Vividrin(®)”) or no nasal spray (natural history). After placebo/nocebo nasal spray administration, cognitive performance was reassessed. Subsequent to the second assessment, participants rated their perceived change in cognitive performance, as well as adverse symptoms. Results: Unlike hypothesized, a positive or negative performance expectation did not result in changes in actual performance, corresponding to the induced expectation. Participants in the placebo-Modafinil group rated their perceived change in cognitive performance subsequent to the application of the nasal spray significantly better (d = 1.16) compared to the nocebo-Vividrin(®) group. Additionally, participants who expected to receive Modafinil felt less tired than participants in the Vividrin(®) group (d = 0.96). Conclusion: Manipulation of performance expectation affects the perceived change in performance and tiredness, but not the actual cognitive performance in healthy adults. This may explain why college students use such drugs despite their little impact on actual cognitive functioning.
format Online
Article
Text
id pubmed-6640161
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66401612019-07-26 Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception Winkler, Alexander Hermann, Christiane Front Psychiatry Psychiatry Objective: The number of students using prescription drugs to improve cognitive performance has increased within the last years. There is first evidence that the expectation to receive a performance-enhancing drug alone can result in improved perceived and actual cognitive performance, suggesting a substantial placebo effect. In addition, expecting a placebo can result in lower perceived and actual cognitive performance, suggesting a nocebo effect. Yet, the underlying mechanisms of these effects remain to be elucidated. The aim of our study was to investigate whether the expectation of receiving a performance-increasing drug or a performance-impairing drug leads to changes in actual and perceived cognitive performance, compared to a control group without expectation manipulation. Methods: A total of N = 75 healthy adults were recruited for an experiment to “try cognitive performance-modulating drugs.” A participant’s actual cognitive performance (alertness, working memory, sustained attention, and divided attention) using the standardized test of attentional performance (TAP) as well as their performance expectation were assessed. Participants were randomly assigned in equal numbers to either receiving a placebo performance increasing nasal spray (“Modafinil”) or a nocebo performance impairing nasal spray (“Vividrin(®)”) or no nasal spray (natural history). After placebo/nocebo nasal spray administration, cognitive performance was reassessed. Subsequent to the second assessment, participants rated their perceived change in cognitive performance, as well as adverse symptoms. Results: Unlike hypothesized, a positive or negative performance expectation did not result in changes in actual performance, corresponding to the induced expectation. Participants in the placebo-Modafinil group rated their perceived change in cognitive performance subsequent to the application of the nasal spray significantly better (d = 1.16) compared to the nocebo-Vividrin(®) group. Additionally, participants who expected to receive Modafinil felt less tired than participants in the Vividrin(®) group (d = 0.96). Conclusion: Manipulation of performance expectation affects the perceived change in performance and tiredness, but not the actual cognitive performance in healthy adults. This may explain why college students use such drugs despite their little impact on actual cognitive functioning. Frontiers Media S.A. 2019-07-12 /pmc/articles/PMC6640161/ /pubmed/31354552 http://dx.doi.org/10.3389/fpsyt.2019.00498 Text en Copyright © 2019 Winkler and Hermann http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Winkler, Alexander
Hermann, Christiane
Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception
title Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception
title_full Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception
title_fullStr Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception
title_full_unstemmed Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception
title_short Placebo- and Nocebo-Effects in Cognitive Neuroenhancement: When Expectation Shapes Perception
title_sort placebo- and nocebo-effects in cognitive neuroenhancement: when expectation shapes perception
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640161/
https://www.ncbi.nlm.nih.gov/pubmed/31354552
http://dx.doi.org/10.3389/fpsyt.2019.00498
work_keys_str_mv AT winkleralexander placeboandnoceboeffectsincognitiveneuroenhancementwhenexpectationshapesperception
AT hermannchristiane placeboandnoceboeffectsincognitiveneuroenhancementwhenexpectationshapesperception